2021
DOI: 10.3389/fphar.2021.748149
|View full text |Cite
|
Sign up to set email alerts
|

Targeting Autophagy with Natural Compounds in Cancer: A Renewed Perspective from Molecular Mechanisms to Targeted Therapy

Abstract: Natural products are well-characterized to have pharmacological or biological activities that can be of therapeutic benefits for cancer therapy, which also provide an important source of inspiration for discovery of potential novel small-molecule drugs. In the past three decades, accumulating evidence has revealed that natural products can modulate a series of key autophagic signaling pathways and display therapeutic effects in different types of human cancers. In this review, we focus on summarizing some repr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 21 publications
(12 citation statements)
references
References 94 publications
1
11
0
Order By: Relevance
“…It is known that serine/threonine protein kinases—AMP-activated protein kinase, mammalian target of rapamycin (mTOR) and unc-51-like kinase 1/2 (Ulk1/2)—are three closely connected junctions in the signaling network that regulates autophagy [ 48 ]. The perspectives and influences of natural compounds on autophagy in cancer were renewed [ 49 ]. The effect of our extracts (DE, SWE) on the level of autophagy in malignant cell lines (breast and cervical) was assessed by the Western blot analysis of the ULK1 protein.…”
Section: Discussionmentioning
confidence: 99%
“…It is known that serine/threonine protein kinases—AMP-activated protein kinase, mammalian target of rapamycin (mTOR) and unc-51-like kinase 1/2 (Ulk1/2)—are three closely connected junctions in the signaling network that regulates autophagy [ 48 ]. The perspectives and influences of natural compounds on autophagy in cancer were renewed [ 49 ]. The effect of our extracts (DE, SWE) on the level of autophagy in malignant cell lines (breast and cervical) was assessed by the Western blot analysis of the ULK1 protein.…”
Section: Discussionmentioning
confidence: 99%
“…Hence, developing relevant drugs targeting autophagy will be a promising strategy for treating diseases that are unavailable with conventional medicinal treatment. Indeed, remarkable progress has been made in discovering small molecules targeting autophagy, such as chloroquine and hydroxychloroquine, in recent years ( Limpert et al, 2018 ; Xiang et al, 2020 ; Xie et al, 2021 ). However, current achievements gradually fail to fulfill the vast and complex drug needs in the clinic.…”
Section: Introductionmentioning
confidence: 99%
“…Clinical management of patients diagnosed with NSCLC initially depends on the diagnosed stage and is subsequently treated using surgical resection, followed by chemo-and/or radiotherapeutics [2]. Nevertheless, although the past few years have witnessed advances in the therapeutic approaches of lung cancer, the overall five-year survival rate is still only 19% [3]. Such poor prognosis in lung cancer patients has been attributed mainly to the development of resistance towards antineoplastic agents [4].…”
Section: Introductionmentioning
confidence: 99%